Anna Oleksiak/Linkedin
May 14, 2026, 13:53
Anna Oleksiak: Managing Anticoagulation Decisions in Critically Ill Cardiac Patients
Anna Oleksiak, Cardiologist at National Institute of Cardiology Stefan Cardinal Wyszyński – National Research Institute, shared a post on LinkedIn:
“Many difficult decisions in the ICCU concern anticoagulation.
We often have to make individual clinical decisions, balancing the risks of bleeding and thrombosis across various indications.
I would like to recommend our chapter 10.2 ‘Managing anticoagulation in critically ill in specific situations’ from Association for Acute CardioVascular Care – ACVC.”
Stay updated with Hemostasis Today.
-
May 14, 2026, 14:00Amro Al-Manasrah: Coronary Reperfusion Injury Beyond Large-Vessel Occlusion
-
May 14, 2026, 13:54Abdul Mannan: The Dual Biology of the Sickle Cell Mutation
-
May 14, 2026, 13:54Pauline Nerwande: Hemostasis and the Balance Between Bleeding and Thrombosis
-
May 14, 2026, 13:46Muhammad Usman: A Practical Overview of Major Blood Components and Their Clinical Use
-
May 14, 2026, 13:34Cynthia Lua: Mental Health Support for Hemophilia Caregivers at the HFA Symposium
-
May 14, 2026, 13:34Nicolas Hubacz: Mapping the Brain’s Mesoscopic Vascular Infrastructure
-
May 14, 2026, 13:20Marcel Émond: When to Restart Anticoagulation After Complex MTBI in the Patient?
-
May 14, 2026, 13:17Amelia Carro Hevia: Improving Heart Failure Care Through Sex-Informed Strategies
-
May 14, 2026, 12:46Ali Sohail: Presenting GI Bleeding and AI Research at DDW 2026